JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB302926

Anti-APOBEC3G/A3G antibody [EPR25404-59]

  • BOND RX™ Validated
  • 20ul selling size
  • RabMAb
  • Recombinant
  • What is this?

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal APOBEC3G/A3G antibody. Suitable for IP, IHC-P, WB and reacts with Human, Transfected cell lysate - Human samples.

View Alternative Names

MDS019, APOBEC3G, DNA dC->dU-editing enzyme APOBEC-3G, APOBEC-related cytidine deaminase, APOBEC-related protein 9, CEM-15, Deoxycytidine deaminase, APOBEC-related protein, ARCD, ARP-9, CEM15, A3G

7 Images
Immunohistochemistry - Anti-APOBEC3G/A3G antibody [EPR25404-59] (AB302926)
  • IHC

Supplier Data

Immunohistochemistry - Anti-APOBEC3G/A3G antibody [EPR25404-59] (AB302926)

Immunohistochemical analysis of paraffin-embedded human breast cancer tissue labeling APOBEC3G/A3G with ab302926 at 1/2000 (0.255 ug/ml) followed by ready to use LeicaDS9800 (Bond® Polymer Refine Detection). Positive staining on immune cells in human breast cancer. The section was incubated with ab302926 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is ready to use LeicaDS9800 (Bond® Polymer Refine Detection). Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.

Immunohistochemistry - Anti-APOBEC3G/A3G antibody [EPR25404-59] (AB302926)
  • IHC

Supplier Data

Immunohistochemistry - Anti-APOBEC3G/A3G antibody [EPR25404-59] (AB302926)

Immunohistochemical analysis of paraffin-embedded wild-type H9 cell pellet labeling APOBEC3G/A3G with ab302926 at 1/2000 (0.255 ug/ml) followed by ready to use LeicaDS9800 (Bond® Polymer Refine Detection). Positive staining on wild-type H9 cell pellet (Panel A); No staining on wild-type Jurkat cell pellet (Panel B); No staining on wild-type 293T cell pellet (Panel C). The section was incubated with ab302926 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is ready to use LeicaDS9800 (Bond® Polymer Refine Detection). Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.

Immunohistochemistry - Anti-APOBEC3G/A3G antibody [EPR25404-59] (AB302926)
  • IHC

Supplier Data

Immunohistochemistry - Anti-APOBEC3G/A3G antibody [EPR25404-59] (AB302926)

Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling APOBEC3G/A3G with ab302926 at 1/2000 (0.255 ug/ml) followed by ready to use LeicaDS9800 (Bond® Polymer Refine Detection). Positive staining on immune cells in human tonsil. The section was incubated with ab302926 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is ready to use LeicaDS9800 (Bond® Polymer Refine Detection). Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.

Immunoprecipitation - Anti-APOBEC3G/A3G antibody [EPR25404-59] (AB302926)
  • IP

Supplier Data

Immunoprecipitation - Anti-APOBEC3G/A3G antibody [EPR25404-59] (AB302926)

APOBEC3G/A3G was immunoprecipitated from 0.35 mg H9 (human lymphoma T lymphocyte) whole cell lysate 20 ug with ab302926 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab302926 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : H9 whole cell lysate 20 ug Lane 2 : ab302926 IP in H9 whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab302926 in H9 whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 15 seconds.

All lanes:

Immunoprecipitation - Anti-APOBEC3G/A3G antibody [EPR25404-59] (ab302926) at 1/1000 dilution

Lane 1:

H9 (human lymphoma T lymphocyte), whole cell lysate 20 μg

Lane 2:

H9, whole cell lysate

Secondary

All lanes:

Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution

Observed band size: 42 kDa

false

Exposure time: 15s

Western blot - Anti-APOBEC3G/A3G antibody [EPR25404-59] (AB302926)
  • WB

Supplier Data

Western blot - Anti-APOBEC3G/A3G antibody [EPR25404-59] (AB302926)

Blocking and diluting buffer and concentration : 5% NFDM/TBST   Exposure time : 180 seconds

All lanes:

Western blot - Anti-APOBEC3G/A3G antibody [EPR25404-59] (ab302926) at 1/1000 dilution

Lane 1:

Human tonsil tissue lysate 20 μg

Lane 2:

Human heart tissue lysate 20 μg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution

Observed band size: 42 kDa

false

Exposure time: 180s

Western blot - Anti-APOBEC3G/A3G antibody [EPR25404-59] (AB302926)
  • WB

Supplier Data

Western blot - Anti-APOBEC3G/A3G antibody [EPR25404-59] (AB302926)

Blocking and diluting buffer and concentration : 5% NFDM/TBST  This antibody does not cross-react with human APOBEC3A or APOBEC3B Exposure time : 180 seconds

All lanes:

Western blot - Anti-APOBEC3G/A3G antibody [EPR25404-59] (ab302926) at 1/1000 dilution

Lane 1:

293T transfected with human APOBEC3G expression vector containi a myc-His-tag®, whole cell lysate, 20 μg

Lane 2:

293T transfected with human APOBEC3A expression vector containi a myc-His-tag®, whole cell lysate, 20 μg

Lane 3:

293T transfected with human APOBEC3B expression vector containi a myc-His-tag®, whole cell lysate, 20 μg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Observed band size: 42 kDa

false

Exposure time: 180s

Western blot - Anti-APOBEC3G/A3G antibody [EPR25404-59] (AB302926)
  • WB

Supplier Data

Western blot - Anti-APOBEC3G/A3G antibody [EPR25404-59] (AB302926)

Blocking and diluting buffer and concentration : 5% NFDM/TBST Negative control : Jurkat (PMID : 14527406) Exposure time : 180 seconds

All lanes:

Western blot - Anti-APOBEC3G/A3G antibody [EPR25404-59] (ab302926) at 1/1000 dilution

Lane 1:

H9 (human lymphoma T lymphocyte), whole cell lysate 20 μg

Lane 2:

Jurkat (human T cell leukemia T lymphocyte), whole cell lysate 20 μg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 42 kDa

false

Exposure time: 180s

  • Carrier free

    Anti-APOBEC3G/A3G antibody [EPR25404-59] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR25404-59

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/2000", "IHCP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/2000", "IHCP-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/2000", "IHCP-species-notes": "<p></p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Transfected cell lysate - Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

APOBEC3G also known as A3G is an enzyme that belongs to the APOBEC family of cytidine deaminases. It has a molecular mass of approximately 46 kDa. This protein is expressed in various tissues including immune cells like lymphocytes and macrophages. A3G plays a mechanical role in catalyzing the deamination of cytidine to uridine on single-stranded DNA which impacts the genetic material of retroviruses.
Biological function summary

APOBEC3G acts as a host defense mechanism against retroviral infections particularly HIV-1. It incorporates into budding virions where it exerts its antiviral effect. A3G functions within the APOBEC protein family complex that participates in innate immunity. This antiviral activity helps to inhibit viral replication by inducing lethal mutations in the viral genome.

Pathways

APOBEC3G is vital in the HIV-1 life cycle disruption pathway. It interacts with other cellular factors such as the viral protein Vif which counters APOBEC3G’s activity by targeting it for proteasomal degradation. The protein is also involved in the regulation of gene expression pathways linked to innate immune responses.

APOBEC3G is associated with HIV-1 infection. Elevated levels of APOBEC3G can lead to the hypermutation of viral DNA potentially reducing viral loads in host cells. The protein’s interaction with HIV-1 Vif protein is critical as Vif facilitates the degradation of A3G allowing the virus to escape its antiviral activity. Additionally researchers investigate a possible connection between A3G and cancer due to its mutation-inducing capability in DNA.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms (PubMed : 12808465, PubMed : 16527742, PubMed : 17121840, PubMed : 18288108, PubMed : 18849968, PubMed : 19153609, PubMed : 21123384, PubMed : 22791714, PubMed : 25542899). Exhibits potent antiviral activity against Vif-deficient HIV-1 (PubMed : 12167863, PubMed : 12859895, PubMed : 14557625, PubMed : 20219927, PubMed : 21835787, PubMed : 22807680, PubMed : 22915799, PubMed : 23097438, PubMed : 23152537, PubMed : 31397674). After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA (PubMed : 12808465, PubMed : 12808466, PubMed : 12809610, PubMed : 12970355, PubMed : 14528300, PubMed : 22807680). The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells (PubMed : 12808465, PubMed : 12808466, PubMed : 12809610, PubMed : 12970355, PubMed : 14528300). Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single- or double-stranded RNA (PubMed : 12808465, PubMed : 12809610, PubMed : 12970355, PubMed : 14528300). Exhibits antiviral activity also against simian immunodeficiency viruses (SIVs), hepatitis B virus (HBV), equine infectious anemia virus (EIAV), xenotropic MuLV-related virus (XMRV) and simian foamy virus (SFV) (PubMed : 15031497, PubMed : 16378963, PubMed : 18448976, PubMed : 19458006, PubMed : 20335265). May inhibit the mobility of LTR and non-LTR retrotransposons (PubMed : 16527742).
See full target information APOBEC3G

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com